From Saturday to Thursday(8:00AM-2:00PM)
Contact us : +9647716699096







  • م.م صادق جعفر رشيد
  • Sadiq Jaafer
  • تدريسي : كلية الصيدلة
  • Teaching : University Of Pharmacy
  • ماجستير علوم صيدلانية
  • Master degree in computer pharmaceuticals science- medicinal chemistry
  • Sadiq@bauc14.edu.iq
  • Sadekjafar82@gmail.com
  • Syllabuses

    Syllabuses - 2
    Dep. Step. Sem. code No. Des. Syllabuses
    University Of Pharmacy three term 1 BHB31IOPHCHE 3 Inorganic pharmaceutical Chemistry
    University Of Pharmacy three term 2 BHB32OR.PHARM.CHEM.I 4 Organic Pharmaceutical Chemistry I

    Research

    2024 IAR Journal of Pharmacy
    "Abstract: Adjective: The purpose of this study was to evaluate the inhibitory effect of the extract derived from Cnicus Benedictus blossom on the growth of cervical cancer cells in a laboratory environment. Furthermore, the study intended to explore any possible synergistic impact when mixing the extract with vinblastine. Method: Hela cancer cell line was utilized to determine the cytotoxicity of Cnicus Benedictus L. floral extract, vinblastine and the mixture between them; the concentration involved was raged between (1-10000) μg/ml, for each one, at 24 and 72 incubation periods. Quantitating drug interaction between mixture components was evaluated by utilizing a compusyn computer program for calculation Combination index (CI) and Dose reduction index. Results: The study showcased the efficacy of plant extract in lessening the growth of cervical cancer cells. The inhibition of growth was seen to be dependent on the concentration and time for both the plant extract and the mixture of plant extract and vinblastine. On the other hand, the cytotoxicity behavior of vinblastine was primarily dependent on time. The result of quantitating drug interaction between mixture components showed diverse behavior, at lower concentration exhibiting synergism, mainly at 24 hrs. incubation period. In contrast, moderate and higher concentrations exhibited antagonism. At the same time, the result of the dose reduction index at 24 hrs. of incubation exhibited a favorable reduction in the concentration of vinblastine in the mixture compared with plant extract. In contrast, at 72 hrs. of incubation, all vinblastine and the majority of plant extract concentrations showed an unfavorable reduction. Conclusion: The study showed that the alcoholic extract of Cnicus Benedictus considerably declined the proliferation of cervical cancer cells corresponding to the inhibitory effect of vinblastine. The result also demonstrates that the mixture of vinblastine and plant extract lessens cervical cancer cell proliferation via cycle-specific and non-cycle-specific cytotoxicity. In contrast, vinblastine predominantly has cycle-specific cytotoxicity. Vinblastine and Cnicus Benedictus L. flower extract have two cytotoxic patterns, synergism at lower combination concentrations and antagonism at intermediate and higher doses."

    2023 Qeios
    "Abstract Background: Protein and peptide drugs offer significant promise as therapeutic agents due to their superior efficacy and reduced toxicity compared to conventional chemical drugs. Nevertheless, difficulties with medication delivery techniques impede their practical deployment. Poor absorption limits non-invasive delivery methods such as nasal, pulmonary, and transdermal distribution, whereas oral administration suffers from low bioavailability and stability problems. Parenteral administration involves certain difficulties, such as low patient compliance and pain, but it also shows promise as a protein-based drug delivery method. Aim: This review article aims to explore the development of structure-based nanocarriers designed for drug delivery, which have shown potential to address the limitations associated with protein and peptide drug delivery. Materials and Methods: A complete literature review was undertaken utilizing Google Scholar and other trustworthy scientific sources to acquire relevant material for this study. Keywords included in the search were “Nanocarriers”, “bioavailability”, “absorption”, “peptide”, “protein drug delivery”, and “permeability”. This review investigated peerreviewed publications, research papers, and reviews relating to the issue of inclusion. Results: The review highlights the advancements in structure-based nanocarriers for protein and peptide drug delivery. These nanocarriers have demonstrated reduced side effects and improved therapeutic efficacy compared to free drug molecules. The ability of new and advanced nanocarriers to facilitate targeted drug delivery, overcome physiological barriers, and enable controlled drug release within the body is discussed. Conclusion: By developing structure-based nanocarriers, the problems with conventional drug delivery techniques may be addressed, and protein and peptide medication delivery can be improved. Potential benefits of these nanocarriers include enhanced absorption, tailored drug administration, and greater bioavailability, which might result in safer and more successful treatment results for a range of illnesses"




    عربي